参考文献/References:
[1] 徐光标,陈德君,陈伟珍.雷公藤多苷片对糖尿病肾病患者临床疗效及炎症因子水平影响研究[J].中华中医药学刊,2017,35(8):2206-2208.DOI:10.13193/j.issn.1673-7717.2017.08.079.
[2] 罗昭强,何隆.玉泉丸对2型糖尿病肾病患者血清炎症因子、β2微球蛋白和VEGF、IGF-1的影响[J].中医药导报,2017,23(15):106-108.DOI:10.13862/j.cnki.cn43-1446/r.2017.15.034.
[3] Qiu YY,Tang LQ.Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy[J].Pharmacol Res,2016,114:251-264.DOI:10.1016/j.phrs.2016.11.004.
[4] Segovia J,Sabbah A,Mgbemena V,et al.TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection[J].PLoS One,2012,7(1):e29695.DOI:10.1371/journal.pone.0029695.
[5] Hutton HL,Ooi JD,Holdsworth SR,et al.The NLRP3 inflammasome in kidney disease and autoimmunity[J].Nephrology(Carlton),2016,21(9):736-744.DOI:10.1111/nep.12785.
[6] Huang W,Gou F,Long Y,et al.High glucose and lipopolysaccharide activate NOD1-RICK-NF-κB inflammatory signaling in mesangial cells[J].Exp Clin Endocrinol Diabetes,2016,124(8):512-517.DOI:10.1055/s-0042-105641.
[7] Bai H,Yang B,Yu W,et al. Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome[J].Exp Cell Res,2018,362(1):180-187.DOI:10.1016/j.yexcr.2017.11.015.
[8] Mirza RE,Fang MM,Weinheimer-Haus EM,et al.Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice[J].Diabetes,2014,63(3):1103-1114.DOI:10.2337/db13-0927.
[9] Feng H,Gu J,Gou F,et al.High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells[J].J Diabetes Res,2016,2016:6973175.DOI:10.1155/2016/6973175.
[10] Boini KM,Xia M,Koka S,et al.Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene[J].Oncotarget,2016,7(14):19031-19044.DOI:10.18632/oncotarget.8023.
[11] Abais JM,Zhang C,Xia M,et al.NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia[J].Antioxid Redox Signal,2013,18(13):1537-1548.DOI:10.1089/ars.2012.4666.
[12] Gao P,Meng XF,Su H,et al. Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy[J].Biochim Biophys Acta,2014,1843(11):2448-2460.DOI:10.1016/j.bbamcr.2014.07.001.
[13] Shahzad K,Bock F,Dong W,et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy[J].Kidney Int,2015,87(1):74-84.DOI:10.1038/ki.2014.271.
[14] Wang Y,Yu B,Wang L,et al.Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus[J].PLoS One,2017,12(7):e0181248.DOI:10.1371/journal.pone.0181248.
[15] Gao P,He FF,Tang H,et al.Erratum to "NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia"[J].J Diabetes Res,2016,2016:1213892.DOI:10.1155/2016/1213892.
[16] Rampanelli E,Orsó E,Ochodnicky P,et al. Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation[J].Sci Rep,2017,7(1):2861.DOI:10.1038/s41598-017-01994-9.
[17] Chen K,Zhang J,Zhang W,et al.ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy[J].Int J Biochem Cell Biol,2013,45(5):932-943.DOI:10.1016/j.biocel.2013.02.009.
[18] Wang F,Huang L,Peng ZZ,et al.Losartan inhibits LPS + ATP-induced IL-1beta secretion from mouse primary macrophages by suppressing NALP3 inflammasome[J].Pharmazie,2014,69(9):680-684.
[19] Wang J,Wen Y,Lv LL,et al.Involvement of endoplasmic reticulum stress in angiotensin Ⅱ-induced NLRP3 inflammasomeactivation in human renal proximal tubular cells in vitro[J].Acta Pharmacol Sin,2015,36(7):821-830.DOI:10.1038/aps.2015.21.
[20] Loboda A,Sobczak M,Jozkowicz A,et al.TGF-β1/smads and miR-21 in renal fibrosis and inflammation[J].Mediators Inflamm,2016,2016:8319283.DOI:10.1155/2016/8319283.
[21] Liao PC,Chao LK,Chou JC,et al.Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion[J].Inflamm Res,2013,62(1):89-96.DOI:10.1007/s00011-012-0555-2.
[22] Müller R,Daniel C,Hugo C,et al.The mitogen-activated protein kinase p38α regulates tubular damage in murine anti-glomerular basement membrane nephritis[J]. PLoS One,2013,8(2):e56316.DOI:10.1371/journal.pone.0056316.
[23] Rajamäki K,Mäyränpää MI,Risco A,et al.p38δ MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis[J].Arterioscler Thromb Vasc Biol,2016,36(9):1937-1946.DOI:10.1161/ATVBAHA.115.307312.
[24] Lorenz G,Darisipudi MN,Anders HJ.Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis[J].Nephrol Dial Transplant,2014,29(1):41-48.DOI:10.1093/ndt/gft332.
[25] Ghonime MG,Shamaa OR,Das S,et al.Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function[J].J Immunol,2014,192(8):3881-3888.DOI:10.4049/jimmunol.1301974.
[26] Sakai N,Wada T,Furuichi K,et al.Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy[J].Am J Kidney Dis,2005,45(1):54-65.
[27] Wan-Xin T,Tian-Lei C,Ben W,et al.Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells[J].J Nephrol,2012,25(6):1023-1030.DOI:10.5301/jn.5000089.
[28] Pastor F,Dumas K,Barthélémy MA,et al.Implication of REDD1 in the activation of inflammatory pathways[J].Sci Rep,2017,7(1):7023.DOI:10.1038/s41598-017-07182-z.
相似文献/References:
[1]李雅,王志斌,刘玮晔,等.巨噬细胞与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
Li Ya*,Wang Zhibin,Liu Weiye,et al.Macrophages and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(04):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
[2]王丹,关美萍,薛耀明.早期生长反应因子-1与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):397.[doi:10.3760/cma.j.issn.1673-4157.2014.06.010]
Wang Dan,Guan Meiping,Xue Yaoming..Early growth response factor-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(04):397.[doi:10.3760/cma.j.issn.1673-4157.2014.06.010]
[3]翟丽敏,叶山东.二甲双胍的抗炎作用及其糖尿病肾脏保护作用[J].国际内分泌代谢杂志,2014,(05):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
Zhai Limin,Ye Shandong..Anti-inflammatory effects of metformin and its renal protection in diabetes[J].International Journal of Endocrinology and Metabolism,2014,(04):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
[4]玄先法,李清芹,王玉新,等.肾炎康复片联合缬沙坦治疗Ⅳ期糖尿病肾病蛋白尿的临床研究[J].国际内分泌代谢杂志,2014,(05):353.[doi:10.3760/cma.j.issn.1673-4157.2014.05.019]
Xuan Xianfa,Li Qingqin,Wang Yuxin,et al.Clinical study of Shenyankangfu tablet combined with valsartan capsule on proteinuria in patients with stage Ⅳ diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(04):353.[doi:10.3760/cma.j.issn.1673-4157.2014.05.019]
[5]曹萌 陈堃 茅晓东 刘超.限食治疗糖尿病肾病的研究进展[J].国际内分泌代谢杂志,2015,(06):395.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.009]
Cao Meng,Chen Kun,Mao Xiaodong,et al.Effects of diet restriction on diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):395.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.009]
[6]于菁 王秋月.多聚ADP核糖聚合酶-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(06):409.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.013]
Yu Jing,Wang Qiuyue..Poly(ADP-ribose)polymerase-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):409.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.013]
[7]马静茹,牟新.表观遗传学与糖尿病肾病[J].国际内分泌代谢杂志,2016,36(01):52.[doi:10.3760/cma.j.issn.1673-4157.2016.01.013]
Ma Jingru*,Mou Xin..Epigenetics and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):52.[doi:10.3760/cma.j.issn.1673-4157.2016.01.013]
[8]杨薇,李春君,孙蓓,等.雷公藤多苷对糖尿病肾病大鼠核因子-κB
信号通路的影响[J].国际内分泌代谢杂志,2016,36(02):107.[doi:10.3760/cma.j.issn.1673-4157.2016.02.008]
Yang Wei*,Li Chunjun,Sun Bei,et al.Effects of triperygium wilfordii polyglucoside on nuclear factor-κB signaling pathway in rats with diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):107.[doi:10.3760/cma.j.issn.1673-4157.2016.02.008]
[9]刘艳,田秀标,韩颖,等.血管紧张素1-7与糖尿病及糖尿病肾脏
内质网应激关系的研究[J].国际内分泌代谢杂志,2016,36(03):157.[doi:10.3760/cma.j.issn.1673-4157.2016.03.04]
Liu Yan*,Tian Xiubiao,Han Ying,et al.Relationship between angiotensin 1-7, diabetes and endoplasmic reticulum stress of diabetic kidney[J].International Journal of Endocrinology and Metabolism,2016,36(04):157.[doi:10.3760/cma.j.issn.1673-4157.2016.03.04]
[10]周宇,柯甦捷,刘礼斌.血尿酸与糖尿病肾病[J].国际内分泌代谢杂志,2016,36(03):202.[doi:10.3760/cma.j.issn.1673-4157.2016.03.15]
Zhou Yu,Ke Sujie,Liu Libin..Serum uric acid and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):202.[doi:10.3760/cma.j.issn.1673-4157.2016.03.15]